logo-loader
view1933 Industries Inc.

1933 Industries sees fiscal 1Q revenue pop thanks to cannabis demand in Western US

Cannabis sales in Nevada, California and Colorado are driving the company's growth

cannabis and related oils
1933, which operates in the US and Canada, owns licensed medical and recreational cannabis cultivation and production assets

1933 Industries Inc (CSE:TGIF) (OTCMKTS:TGIFF) saw its sales soar in its fiscal first quarter on the back of robust demand for cannabis products across Nevada, California and Colorado.

In the three months until the close of October, the cannabis company clocked in with revenue of C$4.62 million, up from C$2.46 million in the corresponding period a year ago.

Its gross profit also jumped over the same period to $1.93 million from $1.162 million. Its current assets climbed as well to $23.76 million from $13.4 million in the previous quarter

“We are pleased to report another strong quarter of steady growth from our subsidiary companies,” said CEO Brayden Sutton in a statement.

“Increased demand for our cannabis products in the states of Nevada, California, and Colorado are continuing to fuel this growth, while we focus on expanding wholesale capacity for our THC line of products and increasing sales of our CBD products across the US,” Sutton added.

READ: Cannabis company 1933 Industries uplists to the OTCQX in the US

1933, which operates in the US and Canada, owns licensed medical and recreational cannabis cultivation and production assets. It controls three subsidiaries, with 91% ownership of both Alternative Medicine Association and Infused MFG and all of Spire Global Strategy.

In the quarter, Alternative Medicine Association reported sales revenue of $2.26 million while Infused MFG posted sales of $2.278 million. Lastly, Spire Global Strategy posted consulting revenue of $81,905.

On 1933’s list of advances for its latest quarter was its launch of Canna Fused, a CBD/THC-infused product line making its debut in Denver in partnership with Denver Dab Company (DDC).

READ: 1933 Industries stokes Las Vegas capacity expansion in anticipation of medical and recreational cannabis product demand

The company also announced that its subsidiary Spire Global Strategy has been awarded a contract to develop a cannabis regulatory compliance course at Selkirk College, a post-secondary institution in British Columbia.

In another quarterly development, 1933 raised gross proceeds of $17.25 million after closing an offering of convertible debenture units.

1933’s net loss for the quarter came in at $3.04 million, or $0.01 per share, compared with a loss of $570,695, or $0.06 per share, in the year-ago period.

1933 shares finished up 2.8% to close at C$0.37 in Canadian trading on Thursday.

Contact Ellen Kelleher at [email protected]

Quick facts: 1933 Industries Inc.

Price: 0.21 CAD

CSE:TGIF
Market: CSE
Market Cap: $59.12 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of 1933 Industries Inc. named herein, including the promotion by the Company of 1933 Industries Inc. in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Buds & Duds: Cannabis shares start week mixed; 1933 Industries gains on new...

Cannabis stocks were mixed on Monday to open the trading week in North America. The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada, stayed relatively flat, inching 0.2% higher to 170 points. Elsewhere, the Horizons Marijuana Life Sciences Index ETF...

on 09/23/2019

2 min read